Medicine
AirDuo RespiClick 113 mcg/14 mcg inhalation powder
AirDuo RespiClick 113 mcg/14 mcg inhalation powder is a prescription medicine containing Fluticasone propionate and Salmeterol for inhalation use, marketed by Teva Respiratory, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature (between 15ºC and 25ºC, 59ºF and 77ºF) in a dry…
Key facts
- Active ingredient (INN)
- Fluticasone propionate and Salmeterol
- Brand
- AirDuo RespiClick
- Strength
- 113 mcg/14 mcg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 1 pouch
- Marketing authorisation holder
- Teva Respiratory
- Manufacturer
- Teva Respiratory
- Origin register
- US FDA, United States
- Storage
- Store at room temperature (between 15ºC and 25ºC, 59ºF and 77ºF) in a dry place, excursions permitted from 59º F to 86º F (15ºC to 30ºC). Store AIRDUO RESPICLICK inside the unopened moisture-protective foil pouch until initial use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03AK06 Fluticasone propionate and Salmeterol
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 April 2017
- Identifiers
- RxCUI 1918194, 1918199, 1918203 +3DailyMed set ID 9c122b91-a11f-49ca-80bb-3eec5112db87NDC 59310-812Application NDA208799
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 1 inhaler in 1 pouch / 60 powder, metered in 1 inhaler | 59310-812-06 | Teva Respiratory | 24 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fluticasone propionate and Salmeterol 113 mcg/14 mcg inhalation powder.
Other strengths and forms of Fluticasone propionate and Salmeterol
Clinical summary
Fluticasone propionate and Salmeterol is a fixed-dose combination of a corticosteroid and a beta2-adrenergic agonist indicated for twice-daily treatment of asthma in patients aged 4 years and older, among other approved uses. MedsAcross supplies Fluticasone propionate and Salmeterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fluticasone propionate and SalmeterolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ADVAIR DISKUS prescribing information (GlaxoSmithKline) · U.S. National Library of Medicine, DailyMed
- Seffalair Spiromax: European public assessment report (EPAR) · European Medicines Agency
Need AirDuo RespiClick 113 mcg/14 mcg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.